Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Exercise program for people with dementia and their caregivers

Official title: Effects of Buddy-Up Dyadic Physical Activity Program on Health Outcomes and Social Dynamic of Persons With Dementia and Family Caregivers: A Mixed Method Randomized Controlled Trial

Run by The University of Hong Kong · NCT06584110 · Data updated 2026-11-12

This study tests a new exercise program for people with mild to early-moderate dementia and their family caregivers to see if it can improve their health and strengthen their relationship.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment236 (estimated)
SponsorThe University of Hong Kong
Academic / other
Locations1 site (Hong Kong, Hong Kong)
StatusRecruiting
StartedOctober 1, 2024
Main results expectedFebruary 15, 2027
Study endsMarch 30, 2027
Registry record updatedNovember 2, 2026
Trial IDNCT06584110 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals diagnosed with mild to early-moderate dementia living with their primary family caregiver.

Probably not a fit

Patients who engage in more than 60 minutes of moderate or vigorous exercise per week or have acute health issues may not benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the Buddy-Up Dyadic Physical Activity (BUDPA) program, which is designed to improve the health outcomes and relationship dynamics of care dyads consisting of individuals with mild to early-moderate dementia and their family caregivers. The program involves partner exercises that promote collaboration and social interaction, addressing the unique challenges faced by caregivers and their loved ones. Over 16 weeks, the study will assess the impact of this intervention on both the physical health of participants and the quality of their caregiving relationship. The approach combines physical activity with a focus on enhancing emotional and social support within the caregiving dyad.

Why it matters

Potential benefit: If successful, this program could enhance the quality of life for both individuals with dementia and their caregivers by improving their physical health and relationship dynamics.

How similar studies have gone: While there is limited research specifically on dyadic exercise programs for dementia, similar interventions focusing on caregiver support and physical activity have shown promise in improving outcomes.

Who can join: the full rules

Show full inclusion / exclusion criteria
Eligibility for person with dementia (PwD) includes i) a confirmed diagnosis of dementia and ii) an HK-MoCA score of 8-19 to indicate mild to early moderate dementia.

The caregivers will have to i) live with the participant with dementia ii) self-identify as the primary family caregiver iii) providing care for ≥ 4 hours/day iv) has a smartphone for FaceTime

The exclusion criteria are i) engaging in ≥60 min/week of moderate or vigorous exercise in the past six months ii) having acute muscular-skeletal problems, cerebro-cardio-respiratory disease or condition contradictory to exercise training

Where it's running

  • The University of Hong Kong
    Hong Kong, Hong Kong, Hong Kong
    Recruiting

Study contacts

  • Principal investigator: SAU FUNG DORIS YU, PhD — The University of Hong Kong
  • Study coordinator: SAU FUNG DORIS YU, PhD
  • Email: dyu1@hku.hk
  • Phone: 852-39176319

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.